Company Filing History:
Years Active: 2007
Title: Henner Graeff: Innovator in Diagnostic and Therapeutic Applications
Introduction
Henner Graeff is a notable inventor based in Munich, Germany. He has made significant contributions to the field of diagnostics and therapeutics, particularly through his innovative work involving antibodies against the urokinase receptor. His research has the potential to impact cancer detection and treatment.
Latest Patents
Henner Graeff holds 1 patent for his invention titled "Diagnostic and therapeutic use of antibodies against the urokinase receptor." This patent describes a method and a reagent kit for detecting cells in a biological sample using a double-fluorescence technique. The invention focuses on the diagnostic and therapeutic application of amino acid sequence-specific antibodies against the urokinase receptor, which exhibit a high affinity for tumor cell-expressed receptors.
Career Highlights
Henner Graeff is associated with Wilex AG, a company that specializes in the development of innovative cancer therapies. His work at Wilex AG has allowed him to explore the therapeutic potential of his inventions in a practical setting. His dedication to advancing medical technology is evident in his research and development efforts.
Collaborations
Henner Graeff has collaborated with notable colleagues, including Manfred Schmitt and Frank Noack. These collaborations have likely contributed to the success of his research and the development of his patented technologies.
Conclusion
Henner Graeff's contributions to the field of diagnostics and therapeutics highlight the importance of innovation in medical science. His work with antibodies against the urokinase receptor represents a significant advancement in cancer detection and treatment.